Amaurosis Fugax: A Rare Oxaliplatin-Induced Ocular Toxicity – A Report of Three Cases
Oxaliplatin, a third-generation platinum-based agent, is a constitutive part of systemic treatment for colorectal cancer in adjuvant and metastatic settings. Ocular toxicity is an extremely rare adverse effect of Oxaliplatin. Ocular toxicities have been documented in the form of (a) common (≥1/100,...
Main Authors: | Mutahar Ali Tunio, Karen Phillips, Peter Baker |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2022-02-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/521842 |
Similar Items
-
Oxaliplatin-Associated Amaurosis Fugax
by: Kimitoshi Kubo, et al.
Published: (2021-06-01) -
Associations among Stroke, Myocardial Infarction, and Amaurosis Fugax in a Tertiary Referral Hospital in Taiwan
by: Ming-Hui Sun, et al.
Published: (2022-08-01) -
Amaurosis fugax: Case report
by: Repac Vinka, et al.
Published: (2016-01-01) -
Redefining amaurosis fugax
by: Paul Varner
Published: (2015-03-01) -
Amaurosis Fugax Preceeding Central Retinal Artery Occlusion : a Case Report
by: Ade John Nursalim, et al.
Published: (2022-06-01)